An insight on promising strategies hoping to cure HIV-1 infection by targeting Rev protein—short review

Human immunodeficiency virus-1 (HIV-1) infection remains to be one of the major threats throughout the world. Many researchers are working in this area to find a cure for HIV-1. The group of the FDA approved drugs which are currently used against HIV-1 in the clinical practice include nucleoside rev...

Descripción completa

Detalles Bibliográficos
Autores principales: Pai, Sahana, Mudgal, Jayesh, Kamath, B. Venkatesh, Pai, K. Sreedhara Ranganath
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8460518/
https://www.ncbi.nlm.nih.gov/pubmed/33840054
http://dx.doi.org/10.1007/s43440-021-00257-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8460518/
https://www.ncbi.nlm.nih.gov/pubmed/33840054
http://dx.doi.org/10.1007/s43440-021-00257-9

Ejemplares similares